300
Participants
Start Date
December 31, 2020
Primary Completion Date
January 31, 2022
Study Completion Date
December 31, 2022
Ulipristal acetate
Ulipristal aceteate 5 mg oral tablets to take two tablets daily.
New York University, School of Medicine, New York
Columbia University, New York
Univeristy of Pittsburgh School of Medicine, Pittsburgh
University of Pennsylvania Medical Center, Philadelphia
Johns Hopkins Bayview Medical Center, Baltimore
Eastern Virginia Medical School (EVMS), Norfolk
University Hospitals of Cleveland MacDonald Women's Hospital, Cleveland
University of Cincinnati, Cincinnati
University of Chicago, Chicago
University of Colorado, Denver
University of Utah, Salt Lake City
Essential Access, Los Angeles
University of California, San Francisco, San Francisco
University of California, Davis, Sacramento
University of Hawaii, Honolulu
Oregon Health & Science University, Portland
Planned Parenthood League of Massachusetts, Boston
Women & Infants Hospital of Rhode Island, Providence
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
Premier Research
OTHER